The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Bronchodilator reversibility testing in chronic obstructive pulmonary disease
Open accessAbstract
BACKGROUND: A limited or absent bronchodilator response is used to classify chronic obstructive pulmonary disease (COPD) and can determine the treatment offered. The reliability of the recommended response criteria and their relationship to disease progression has not been established. METHODS: 660 patients meeting European Respiratory Society (ERS) diagnostic criteria for irreversible COPD were studied. Spirometric parameters were measured on three occasions before and after salbutamol and ipratropium bromide sequentially or in combination over 2 months. Responses were classified using the American Thoracic Society/GOLD (ATS) and ERS criteria. Patients were followed for 3 years with post-bronchodilator FEV(1) and exacerbation history recorded 3 monthly and health status 6 monthly. RESULTS: FEV(1) increased significantly with each bronchodilator, a response that was normally distributed. Mean post-bronchodilator FEV(1) was reproducible between visits (intraclass correlation 0.93). The absolute change in FEV(1) was independent of the pre-bronchodilator value but the percentage change correlated with pre-bronchodilator FEV(1) (r=-0.44; p<0.0001). Using ATS criteria, 52.1% of patients changed responder status between visits compared with 38.2% using ERS criteria. Smoking status, atopy, and withdrawing inhaled corticosteroids were unrelated to bronchodilator response, as was the rate of decline in FEV(1), decline in health status, and exacerbation rate. CONCLUSION: In moderate to severe COPD bronchodilator responsiveness is a continuous variable. Classifying patients as "responders" and "non-responders" can be misleading and does not predict disease progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
Standardization of Spirometry, 1994 Update. American Thoracic Society.
(1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.3.7663792 · Cited by 6,594
PAUWELS, R. A., BUIST, A. S., CALVERLEY, P. M. A., JENKINS, C. R., & HURD, S. S. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.5.2101039 · Cited by 6,587
Self-citationLung volumes and forced ventilatory flows
Quanjer, P. H., Tammeling, G. J., Cotes, J. E., Pedersen, O. F., Peslin, R., & Yernault, J.-C. (1993) · European Respiratory Journal · doi:10.1183/09041950.005s1693 · Cited by 5,318
(1993) · PubMed · Cited by 3,827
Standards for the Diagnosis and Care of Patients with Chronic Obstructive Pulmonary Disease
Celli, B. R., Snider, G. L., Heffner, J. E., Tiep, B. L., Ziment, I., Make, B. J., Braman, S. S., Olsen, G. N., & D, Y. Y. P. M. (1995) · Cited by 3,506
An Introduction to Medical Statistics.
(1931) · Journal of the American Medical Association · doi:10.1001/jama.1931.02730150055037 · Cited by 2,084
Siafakas, N., Vermeire, P., Pride, N., Paoletti, P., Gibson, J., Howard, P., Yernault, J., Decramer, M., Higenbottam, T., Postma, D., et al. (1995) · European Respiratory Journal · doi:10.1183/09031936.95.08081398 · Cited by 1,592
Pauwels, R. A., Löfdahl, C.-G., Laitinen, L. A., Schouten, J. P., Postma, D. S., Pride, N. B., & Ohlsson, S. V. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906243402503 · Cited by 1,074
Prognosis in Chronic Obstructive Pulmonary Disease 1– 3
Anthonisen, N. R., Wright, E. C., Hodgkin, J. E., & IPPB Trial Group (1986) · American Review of Respiratory Disease · doi:10.1164/arrd.1986.133.1.14 · Cited by 777
Guidelines for the management of chronic obstructive pulmonary disease
Buist, A. S. (2002) · Respiratory Medicine · doi:10.1016/s0954-6111(02)80029-4 · Cited by 607
Quality of life changes in COPD patients treated with salmeterol.
Jones, P. W., & Bosh, T. K. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.155.4.9105068 · Cited by 494
An Introduction to Medical Statistics.
Campbell, M. J., & Bland, M. (1988) · Journal of the Royal Statistical Society. Series A (Statistics in Society) · doi:10.2307/2982768 · Cited by 317
Spirometry in the Lung Health Study: 1. Methods and Quality Control
Enright, P. L., Johnson, L. R., Connett, J. E., Voelker, H., & Buist, A. S. (1991) · American Review of Respiratory Disease · doi:10.1164/ajrccm/143.6.1215 · Cited by 296
Bronchodilator response in chronic obstructive pulmonary disease.
Anthonisen, N., & Ec, W. (1986) · PubMed · Cited by 233
Callahan, C. M., Dittus, R. S., & Katz, B. P. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-3-216 · Cited by 233
Brand, P. L., Quanjer, P. H., Postma, D. S., Kerstjens, H. A., Koeter, G. H., Dekhuijzen, P. N., & Sluiter, H. J. (1992) · Thorax · doi:10.1136/thx.47.6.429 · Cited by 212
Hay, J., Stone, P., Carter, J., Church, S., Eyre-Brook, A., Pearson, M., Woodcock, A., & Calverley, P. (1992) · European Respiratory Journal · doi:10.1183/09031936.93.05060659 · Cited by 195
Self-citationPrognosis in Chronic Obstructive Pulmonary Disease
Hodgkin, J. E. (1990) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(21)00717-6 · Cited by 187
Tweeddale, P. M., Alexander, F., & McHardy, G. J. (1987) · Thorax · doi:10.1136/thx.42.7.487 · Cited by 177
Jarad, N. A., Wedzicha, J. A., Burge, P. S., & Calverley, P. M. A. (1999) · Respiratory Medicine · doi:10.1016/s0954-6111(99)90001-x · Cited by 160
Self-citationCholinergic Bronchomotor Tone in COPD
Gross, N. J., Co, E., & Skorodin, M. S. (1989) · CHEST Journal · doi:10.1378/chest.96.5.984 · Cited by 129
Gross, N. J., Petty, T. L., Friedman, M. B., Skorodin, M. S., Silvers, G. W., & Donohue, J. F. (1989) · American Review of Respiratory Disease · doi:10.1164/ajrccm/139.5.1188 · Cited by 124
High-dose Inhaled Albuterol in Severe Chronic Airflow Limitation
Vathenen, A. S., Britton, J. R., Ebden, P., Cookson, J., Wharrad, H. J., & Tattersfield, A. E. (1988) · American Review of Respiratory Disease · doi:10.1164/ajrccm/138.4.850 · Cited by 115
Kerstjens, H. A. M., Overbeek, S. E., Schouten, J. P., Brand, P., & Postma, D. S. (1993) · European Respiratory Journal · doi:10.1183/09031936.93.06060868 · Cited by 91
Risk Factors for Accelerated Decline Among Patients With Chronic Obstructive Pulmonary Disease
Kerstjens, H. A. M., Brand, P. L. P., & Postma, D. S. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm/154.6_pt_2.s266 · Cited by 36
Oral corticosteroid trials in the management of stable chronic obstructive pulmonary disease
Davies, L. (1999) · QJM · doi:10.1093/qjmed/92.7.395 · Cited by 28
Löfdahl, C. G., Postma, D. S., Laitinen, L. A., Ohlsson, S. V., Pauwels, R., & Pride, N. B. (1998) · Respiratory Medicine · doi:10.1016/s0954-6111(98)90293-1 · Cited by 22
Cited by
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
Rabe, K. F., Hurd, S., Anzueto, A., Barnes, P. J., Buist, S. A., Calverley, P., Fukuchi, Y., Jenkins, C., Rodriguez-Roisin, R., van Weel, C., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200703-456so · Cited by 4,925
“Despite earlier hopes, neither bronchodilator nor oral glucocorticosteroid reversibility testing predicts disease progression, whether judged by decline in FEV1, deterioration of health status, or frequency of exacerbations (67, 68) in patients with a clinical diagnosis of COPD and abnormal spirometry (68).”
BackgroundSelf-citationChanges in Forced Expiratory Volume in 1 Second over Time in COPD
Vestbo, J., Edwards, L. D., Scanlon, P. D., Yates, J. C., Agusti, A., Bakke, P., Calverley, P. M. A., Celli, B., Coxson, H. O., Crim, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105482 · Cited by 963
Self-citationOutcomes for COPD pharmacological trials: from lung function to biomarkers
Cazzola, M., MacNee, W., Martinez, F. J., Rabe, K. F., Franciosi, L. G., Barnes, P. J., Brusasco, V., Burge, P. S., Calverley, P. M. A., Celli, B. R., et al. (2008) · European Respiratory Journal · doi:10.1183/09031936.00099306 · Cited by 858
Self-citationManagement of Chronic Obstructive Pulmonary Disease
Sutherland, E. R., & Cherniack, R. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmra030415 · Cited by 563
Metadata
- Authors
- Calverley, P. M. A.
- Venue
- Thorax
- Publisher
- BMJ
- Published
- 2003-08-01
- Volume
- 58
- Issue
- 8
- Pages
- 659-664
- ISSN
- 0040-6376 (ISSN-L)
- OpenAlex
- W2143454168
- Cited by
- 512
- References
- 29
- FWCI
- 33.92
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.